Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1993
New anticancer agents
G R Weiss, H A Burris, J R Eckardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2008
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
M L Rothenberg, J V Cox, C Butts, et al.
Cancer Chemotherapy and Pharmacology
|
November 9, 2006
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors
A C Lockhart, R Bukowski, M L Rothenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials
J A O'Shaughnessy, R E Wittes, G Burke, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1996
New anticancer agents
G R Weiss, H A Burris 3rd, J R Eckardt, et al.
American Journal of Clinical Oncology
|
December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon
J R Eckardt, E Campbell, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Phase I and pharmacokinetic trial of weekly CPT-11
M L Rothenberg, J G Kuhn, H A Burris, et al.
Biopharmaceutics & Drug Disposition
|
May 1, 1997
Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin
W D Figg, M C Christian, R Lush, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study
M L Rothenberg, J K Benedetti, J S Macdonald, et al.
Gynecologic Oncology
|
September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)
M L Rothenberg, P Y Liu, S Wilczynski, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1993
New anticancer agents
G R Weiss, H A Burris, J R Eckardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2008
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
M L Rothenberg, J V Cox, C Butts, et al.
Cancer Chemotherapy and Pharmacology
|
November 9, 2006
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors
A C Lockhart, R Bukowski, M L Rothenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials
J A O'Shaughnessy, R E Wittes, G Burke, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1996
New anticancer agents
G R Weiss, H A Burris 3rd, J R Eckardt, et al.
American Journal of Clinical Oncology
|
December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon
J R Eckardt, E Campbell, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Phase I and pharmacokinetic trial of weekly CPT-11
M L Rothenberg, J G Kuhn, H A Burris, et al.
Biopharmaceutics & Drug Disposition
|
May 1, 1997
Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin
W D Figg, M C Christian, R Lush, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study
M L Rothenberg, J K Benedetti, J S Macdonald, et al.
Gynecologic Oncology
|
September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)
M L Rothenberg, P Y Liu, S Wilczynski, et al.
Page
of 7